151 related articles for article (PubMed ID: 16115232)
21. Loss of p16INK4A expression in low-grade ovarian serous carcinomas.
Schlosshauer PW; Deligdisch L; Penault-Llorca F; Fatemi D; Qiao R; Yao S; Pearl M; Yang Z; Sheng T; Dong J
Int J Gynecol Pathol; 2011 Jan; 30(1):22-9. PubMed ID: 21131838
[TBL] [Abstract][Full Text] [Related]
22. KRAS mutation of extraovarian implants of serous borderline tumor: prognostic indicator for adverse clinical outcome.
Zuo T; Wong S; Buza N; Hui P
Mod Pathol; 2018 Feb; 31(2):350-357. PubMed ID: 29027536
[TBL] [Abstract][Full Text] [Related]
23. Pathology of borderline (low malignant potential) ovarian tumours.
Seidman JD; Ronnett BM; Kurman RJ
Best Pract Res Clin Obstet Gynaecol; 2002 Aug; 16(4):499-512. PubMed ID: 12413931
[TBL] [Abstract][Full Text] [Related]
24. Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes.
Jönsson JM; Johansson I; Dominguez-Valentin M; Kimbung S; Jönsson M; Bonde JH; Kannisto P; Måsbäck A; Malander S; Nilbert M; Hedenfalk I
PLoS One; 2014; 9(9):e107643. PubMed ID: 25226589
[TBL] [Abstract][Full Text] [Related]
25. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.
Jamieson S; Alexiadis M; Fuller PJ
Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971
[TBL] [Abstract][Full Text] [Related]
26. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
Evans MF; McDicken IW; Herrington CS
J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
[TBL] [Abstract][Full Text] [Related]
27. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
28. [Molecular carcinogenesis of ovarian carcinoma].
Diebold J
Verh Dtsch Ges Pathol; 2005; 89():77-83. PubMed ID: 18035676
[TBL] [Abstract][Full Text] [Related]
29. In vitro fertilization following conservative management of stage 3 serous borderline tumor of the ovary.
Hoffman JS; Laird L; Benadiva C; Dreiss R
Gynecol Oncol; 1999 Sep; 74(3):515-8. PubMed ID: 10479523
[TBL] [Abstract][Full Text] [Related]
30. Ovarian-type epithelial tumours of the testis: immunohistochemical and molecular analysis of two serous borderline tumours of the testis.
Bürger T; Schildhaus HU; Inniger R; Hansen J; Mayer P; Schweyer S; Radzun HJ; Ströbel P; Bremmer F
Diagn Pathol; 2015 Jul; 10():118. PubMed ID: 26197800
[TBL] [Abstract][Full Text] [Related]
31. Micropapillary pattern in serous borderline ovarian tumors: does it matter?
Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
Gynecol Oncol; 2011 Dec; 123(3):511-6. PubMed ID: 21917305
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
[TBL] [Abstract][Full Text] [Related]
33. Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures.
Curry EW; Stronach EA; Rama NR; Wang YY; Gabra H; El-Bahrawy MA
Mod Pathol; 2014 Mar; 27(3):433-42. PubMed ID: 23948749
[TBL] [Abstract][Full Text] [Related]
34. Ovarian tumours: a study of 282 cases.
Pilli GS; Suneeta KP; Dhaded AV; Yenni VV
J Indian Med Assoc; 2002 Jul; 100(7):420, 423-4, 447. PubMed ID: 12674165
[TBL] [Abstract][Full Text] [Related]
35. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
[TBL] [Abstract][Full Text] [Related]
36. MRI appearances of borderline ovarian tumours.
Bent CL; Sahdev A; Rockall AG; Singh N; Sohaib SA; Reznek RH
Clin Radiol; 2009 Apr; 64(4):430-8. PubMed ID: 19264189
[TBL] [Abstract][Full Text] [Related]
37. The mutational profile of sporadic epithelial ovarian carcinoma.
Kalamanathan S; Bates V; Lord R; Green JA
Anticancer Res; 2011 Aug; 31(8):2661-8. PubMed ID: 21778320
[TBL] [Abstract][Full Text] [Related]
38. Possible metaplastic origin of lymph node "metastases" in serous ovarian tumor of low malignant potential (borderline serous tumor).
Kadar N; Krumerman M
Gynecol Oncol; 1995 Dec; 59(3):394-7. PubMed ID: 8522262
[TBL] [Abstract][Full Text] [Related]
39. Molecular genetic analysis of ovarian serous cystadenomas.
Cheng EJ; Kurman RJ; Wang M; Oldt R; Wang BG; Berman DM; Shih IeM
Lab Invest; 2004 Jun; 84(6):778-84. PubMed ID: 15077125
[TBL] [Abstract][Full Text] [Related]
40. Serous tumors of low malignant potential of the ovary. 1. Diagnostic pathology.
Dietel M; Hauptmann S
Virchows Arch; 2000 May; 436(5):403-12. PubMed ID: 10881733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]